Meperia

Meperia, based in the US, provides innovative healthcare supply chain solutions that optimize procurement and inventory management, aiming to reduce costs and improve efficiency for healthcare providers. Founded in 2009 in Vero Beach, US, Meperia specializes in healthcare supply chain management solutions. The company has adapted its strategies to enhance service delivery, focusing on artificial intelligence applications in procurement. In November 2025, Genesis Automation LTD a portfolio company of Diversis Capital acquired Meperia.

Financial terms of the transaction were not disclosed. Meperia Strategic Sourcing & Implant Management Solutions offers an extensive range of healthcare supply chain and inventory management tools. Their offerings include a formulary-based procurement solution that employs advanced artificial intelligence to identify functional equivalences among medical products. This platform integrates various systems within healthcare organizations, providing a unified view of supply chain data across multiple facilities.

With a client base including hospitals, outpatient facilities, and healthcare systems, Meperia caters to the specific needs of over 3,500 physicians across North America and selected regions in Europe. Meperia operates primarily on a SaaS (Software as a Service) model, where clients subscribe to access procurement and inventory management tools through multi-year contracts. The pricing structure is tiered, allowing for tailored solutions based on organizational size and service scope. Their flagship product features predictive intelligence and real-time data analytics, enabling healthcare organizations to streamline purchasing while adhering to formulary rules.

In November 2025, Meperia secured investment from Diversis Capital, which will facilitate its expansion into the United States, United Kingdom, and Ireland. The funding will support the development of new products aimed at enhancing procurement processes in these markets. Specific details regarding upcoming product launches have not been disclosed, but the investment is intended to bolster Meperia's presence and service capabilities in the targeted regions.